Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
Feature
lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017 Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
News
georgescangos

Vir Biotech blasts out of the blocks, with $500m in bank

October 19, 2017 Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …
News

Novo’s diabetes treatment semaglutide gets unanimous FDA backing

October 19, 2017 Sales and Marketing Novo Nordisk, diabetes, semaglutide

Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …
News
gilead-sciences

Gilead gets FDA nod for revolutionary blood cancer treatment

October 19, 2017 Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical

Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …
News

J&J’s third quarter: The good and the bad

October 18, 2017 Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be …
News

Allergan’s patent shield – The (Native) American dream?

October 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

  In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering …
Feature
5440392565_4634fb9d24_z

Trump suggests he will declare opioid national emergency next week

October 17, 2017 Manufacturing and Production, Sales and Marketing President trump, Trump, biotech, drugs, pharma, pharmaceutical

Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a …
News
shutterstock_79370437

Asking the right questions: Measuring the impact of pharmacovigilance

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
Feature
veeva

Simplify your regulatory processes

October 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product variations, …
News
prevail_-_ebola_vaccination

Trials reveal two strong vaccine candidates for Ebola

October 16, 2017 Research and Development, Sales and Marketing Ebola, biotech, drugs, pharma, pharmaceutical

Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged. The two therapies …
News
janssen_latest_logo_on_sign

FDA expands Janssen’s Stelara to cover adolescent psoriasis patients

October 16, 2017 Sales and Marketing FDA, Janssen, Stelara, pharma, psoriasis

Janssen has announced that the FDA has approved an expanded indication for its psoriasis therapy Stelara (ustekinumab) for the treatment …
News
astrazeneca_plaque

AstraZeneca admits cancer data for acquired drug was fabricated

October 16, 2017 Research and Development, Sales and Marketing Acerta, AstraZeneca, acalabrutinib

AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers …
News
roche__tree

Roche launches Warp Drive antibiotic collaboration for $387m

October 16, 2017 Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical

Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, pharmaceuticals, top ten

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026